ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Statistical methods"

  • Abstract Number: 0479 • ACR Convergence 2024

    Constructing and Using a Novel Nucleotide Transformer for Patients with Rheumatoid Arthritis

    Shant Ayanian, Collin Osborne, Marc Blasi, Daniel Darveaux, Eric Klee and Elena Myasoedova, Mayo Clinic, Rochester, MN

    Background/Purpose: Applying the methods of artificial intelligence (AI) to genomic data for clinical outcome prediction in rheumatoid arthritis (RA) is an area of growing research.…
  • Abstract Number: 0492 • ACR Convergence 2024

    A Machine Learning Model for the Early Identification of Rheumatoid Arthritis: Development and Validation

    Michael Dreyfuss1, Yonatan Jenudi2, Dan Riesel3, Or Ramni3, Daniel Underberger4, Benjamin Getz5, Shlomit Steinberg-Koch3, Douglas White6 and Elena Myasoedova7, 1Predicta Med, Ramat Gan, Israel, 2[email protected], Ramat Gan, Israel, 3Predicta Med Analytics Ltd., Ramat Gan, Israel, 4Predicta Med Analytics Ltd., Bridgeport, CT, 5CTO, Ramat Gan, Israel, 6Gundersen Health System, Onalaska, WI, 7Mayo Clinic, Rochester, MN

    Background/Purpose: Patients with rheumatoid arthritis often experience clinically significant delays in diagnosis (Sørensen et al., 2015; Raza et al., 2011). RA can present similarly to…
  • Abstract Number: 0545 • ACR Convergence 2024

    Missing Data in Observational Studies: Investigating Cross-sectional Single Imputation Methods for Assessing Disease Activity in Axial Spondyloarthritis

    Stylianos Georgiadis1, Marion Pons2, Simon Horskjær Rasmussen2, Merete Hetland3, Louise Linde2, Daniela DiGuiseppe4, Brigitte Michelsen5, Johan Karlsson Wallman6, Tor Olofsson7, Karel Pavelka8, Jakub Závada8, Bente Glintborg9, Anne Gitte Loft10, Catalin Codreanu11, Daniel Melim12, Diogo Esperança Almeida13, Tore K. Kvien14, Vappu Rantalaiho15, Ritva Peltomaa16, Bjorn Gudbjornsson17, Olafur Palsson18, Ovidiu Rotariu19, Ross MacDonald19, Ziga Rotar20, Katja Perdan-Pikmajer20, Karin Laas21, Florenzo Iannone22, Adrian Ciurea23, Mikkel Ostergaard24 and Lykke Oernbjerg1, 1Rigshospitalet Glostrup, Glostrup, Hovedstaden, Denmark, 2Rigshospitalet Glostrup, Glostrup, Denmark, 3Rigshospitalet Glostrup and University of Copenhagen, Glostrup, Denmark, 4Karolinska Institutet, Stockholm, 5Rigshospitalet Glostrup, Diakonhjemmet Hospital and Sørlandet Hospital, Copenhagen, Denmark, 6Lund University, Department of Clinical Sciences Lund, Section of Rheumatology and Skåne University Hospital, Lund, Sweden, Lund, Skane Lan, Sweden, 7Lund University, Department of Clinical Sciences Lund, Section of Rheumatology and Skåne University Hospital, Lund, Sweden, Lund, Sweden, 8Institute of Rheumatology and Charles University, Praha, Czech Republic, 9DANBIO, Rigshospitalet Glostrup and University of Copenhagen, Virum, Denmark, 10Aarhus University Hospital and Aarhus University, Horsens, Denmark, 11University of Medicine and Pharmacy, Bucharest, Romania, 12Hospital Egas Moniz, Lisbon, Portugal, 13Hospital de Braga, Braga, Portugal, 14Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway and University of Oslo (UiO), Institute of Clinical Medicine, Oslo, Norway, Oslo, Norway, 15Tampere University Hospital, Tampere University and Kanta-Häme Central Hospital, Tampere, Finland, 16Helsinki University Hospital and University of Helsinki, Helsinki, Finland, 17Landspitali University Hospital and University of Iceland, Reykjavik, Iceland, 18University of Iceland and Skåne University Hospital, Reykjavik, Iceland, 19University of Aberdeen, Aberdeen, United Kingdom, 20University Medical Centre Ljubljana and University of Ljubljana, Ljubljana, Slovenia, 21East-Tallinn Central Hospital, Tallinn, Estonia, 22Rheumatology Unit- University of Bari "Aldo Moro", IT, Bari, Italy, 23University Hospital Zurich, Zürich, Switzerland, 24Department of Clinical Medicine, University of Copenhagen and Center for Rheumatology, Copenhagen Center for Arthritis Research, Glostrup, Denmark

    Background/Purpose: In observational studies, several longitudinal methods have been proposed to impute missing data of an individual by using the available information of the same…
  • Abstract Number: 0754 • ACR Convergence 2024

    Clinical Characterization of Aortitis and Periaortitis in a Cohort of 134 Patients from a Single Universitary Center. A Model-based Cluster Analysis

    Carmen Secada Gómez1, Javier Loricera2, Adrián Martín-Gutiérrez3, Fernando Lopez-Gutierrez4, María Nuñez-Sayar5, Ander Ucelay-Aristi5, Isabel Martinez-Rodriguez6, ivan Ferraz-Amaro7, Santos Castañeda8 and Ricardo Blanco-Alonso9, 1Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain, 2Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain, 3Hospital Universitario Marques de Valdecilla, IDIVAL, Renedo de Piélagos, Cantabria, Spain, 4Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Cantabria, Spain, 5Cardiovascular Surgery, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain, 6Nuclear Medicine, Hospital Universitario Marques de Valdecilla,IDIVAL, Santander, Cantabria, Spain, 7Rheumatology, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Canarias, Spain, 8Hospital Universitario de la Princesa, Madrid, Spain, 9Division of Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Immunopathology group, Santander, Spain

    Background/Purpose: Aortitis and periaortitis represent the inflammation of the aortic wall and the surrounding periaortic tissues, respectively. Both can be idiopathic or secondary to infectious…
  • Abstract Number: 0885 • ACR Convergence 2024

    Reproducible Single Cell Annotation of Programs Underlying T-cell Subsets, Activation States, and Functions

    Dylan Kotliar1, Michelle Curtis1, Ryan Agnew1, Kathryn Weinand1, Aparna Nathan2, Yuriy Baglaenko1, Yu Zhao1, Pardis Sabeti3, Deepak Rao4 and Soumya Raychaudhuri1, 1Brigham and Women's Hospital, Boston, MA, 2Harvard Medical School, Boston, MA, 3Broad Institute, Boston, MA, 4Brigham and Women's Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: T-cells play a key role in the pathogenesis of autoimmune disease and in protection against cancer and infection. Consequently, there is widespread interest in…
  • Abstract Number: 1109 • ACR Convergence 2024

    Differences Between Correlation and Causal Inference in Detecting Predictors of Undefined Crystal Arthropathy in Women

    Laura Scagnellato1, Antonio Collesei2, Sonia farah3, Carlomaurizio Montecucco4, Francesca Oliviero5, Bernd raffeiner6, Marta favero5, Amelia Damasco5, doria Andrea5, Fausto Salaffi3 and Roberta Ramonda7, and SIR Study Group on Crystal Arthropaties, 1Rheumatology Unit, University of Padova, Padova, Italy, 2IRCCS Istituto Oncologico Veneto IOV, Padova, Italy, 3Polytechnic University of Marche, Jesi (AN), Italy, 4IRCCS policlinico S. Matteo foundation, University of Pavia, Pavia, Italy, 5University of Padova, Padova, Italy, 6General Hospital of Bolzano, Bolzano, Italy, 7Rheumatology Unit, University of Padova, Italy, Padova, Italy

    Background/Purpose: Crystal arthropaties, including gout and calcium pyrophosphate deposition disease (CPPD), are prevalent and burdensome conditions. The ALLSTAR model allows the identification of reliable causal,…
  • Abstract Number: 1191 • ACR Convergence 2024

    Discordant Associations Among Chronological and Biological Age with Multi-joint Osteoarthritis and Symptom Burden: The Johnston County Health Study

    Liubov Arbeeva1, Yvonne Golightly2, Cameron Kurz3, Matlock Jeffries4, Virginia Kraus5, Richard Loeser6, Duncan Lascelles7 and Amanda Nelson3, 1University of North Carolina, Chapel Hill, Carrboro, NC, 2University of Nebraska Medical Center, Omaha, NE, 3University of North Carolina at Chapel Hill, Chapel Hill, NC, 4Oklahoma Medical Research Foundation, Oklahoma City, OK, 5Duke University, Durham, NC, 6University of North Carolina, Chapel Hill, NC, 7North Carolina State University, Raleigh, NC

    Background/Purpose: Biological age (BA) may be superior to chronological age (CA) in predicting mortality and age-related conditions such as diabetes and cognitive/functional decline (PMID35715611), as…
  • Abstract Number: 1207 • ACR Convergence 2024

    Patterns of Shared Variation in Knee Ultrasound for Osteoarthritis: A Machine Learning Approach

    Sahar Sawani1, Liubov Arbeeva2, Katherine Yates3, Carolina Alvarez4, Todd Schwartz1, Serena Savage-Guin5, Jordan Renner6, Catherine Bakewell7, Minna Kohler8, Janice Lin9, Jonathan Samuels10 and Amanda Nelson1, 1University of North Carolina at Chapel Hill, Chapel Hill, NC, 2University of North Carolina, Chapel Hill, Carrboro, NC, 3University of North Carolina Medical Center, Chapel Hill, NC, 4University of North Carolina at Chapel Hill, Miami, FL, 5Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill,, Chapel Hill, NC, 6Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 7Intermountain Health Care, Salt Lake City, UT, 8Massachusetts General Hospital, Boston, MA, 9Stanford University, Palo Alto, CA, 10NYU Langone, Rye Brook, NY

    Background/Purpose: The aim of this study was to utilize a machine learning (ML) approach to identify phenotypes of knee OA (KOA) based on demographic variables,…
  • Abstract Number: 1404 • ACR Convergence 2024

    Modeling Diversity in Systemic Lupus Erythematosus (SLE) Clinical Trials Using Real-world Data (RWD) Sources

    Andrew Bevan1 and Nora Carroll2, 1Integrated Project Solutions, PPD, part of Thermo Fisher Scientific, Cambridge, United Kingdom, 2Cardiovascular and General Medicine, Thermo Fisher Scientific, Athlone, Ireland

    Background/Purpose: The FDA places emphasis on studying clinically relevant trial populations but does not address how these might be defined. SLE disproportionately affects women and…
  • Abstract Number: 1409 • ACR Convergence 2024

    Salivary Organoids Contain More Diverse Epithelial and Less Mesenchymal Cells Than Adherent Cultures: Choose Your Sjögren’s Disease Research Tool Carefully

    Ting Yang1, Abel Soto Gamez1, Janneke Terpstra1, Hendrika Bootsma2, Arjan Vissink1, Frans Kroese3 and Sarah Pringle3, 1UMCG, Groningen, Netherlands, 2Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Groningen, Netherlands, 3University Medical Center Groningen, Groningen, Netherlands

    Background/Purpose: The majority of the critical pieces of work probing the involvement of the salivary gland (SG) epithelium in Sjogren’s Disease (SjD) employ salivary gland…
  • Abstract Number: 1728 • ACR Convergence 2024

    Higher Oral Steroid Dose Is Associated with Worse Survival in Immune Checkpoint Inhibitor-Treated Rheumatoid Arthritis Patients with Metastatic Non-Small Cell Lung Cancer

    Deanna Jannat-Khah1, Jeffrey Curtis2, Fenglong Xie3, Ashish Saxena4 and Anne Bass5, 1Hospital For Special Surgery, New York, NY, 2The University of Alabama at Birmingham, Birmingham, AL, 3University of Alabama at Birmingham, Birmingham, AL, 4Weill Cornell Medicine, New York, NY, 5Hospital for Special Surgery, Weill Cornell Medicine, New York, NY

    Background/Purpose: It is unknown if steroid use for RA patients could interfere with the benefits of immune checkpoint inhibitors (ICI) as cancer therapies. Additionally, it…
  • Abstract Number: 0123 • ACR Convergence 2023

    Improving Interpretation of Work Outcomes in Patients with Inflammatory Rheumatic Musculoskeletal Disease: General Population Reference Curves for Work Ability and At-work Productivity

    Dafne Capelusnik1, Wouter Smeets2, Casper Webers3, Sofia Ramiro4, Elena Nikiphorou5, Roel Braekers2, Laura Boekel6, Gertjan Wolbink7 and Annelies Boonen8, 1Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 2Data science institute, Hasselt University, Hasselt, Belgium, 3Maastricht University, Maastricht, Netherlands, 4Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 5King's College London, London, United Kingdom, 6Amsterdam Rheumatology and Immunology Center, Location Reade, Department of Rheumatology, Amsterdam, Netherlands, 7Reade, Amsterdam, Netherlands, 8Care and Public Health Research Institute (Caphri), Maastricht University, Maastricht, Netherlands

    Background/Purpose: Data on self-reported presenteeism (limitations or reduced work productivity at work) in persons with inflammatory rheumatic and musculoskeletal diseases (iRMD) are challenging to interpret…
  • Abstract Number: 0175 • ACR Convergence 2023

    Predicting Cost-Related Medication Non-Adherence in US Adults with Chronic Arthritis: A Machine Learning Approach

    Ashkan Ara1, Matthew Chenoweth1 and Christopher Scannell2, 1University of California Los Angeles, Los Angeles, CA, 2UCLA / West Los Angeles VA Medical Center, Los Angeles, CA

    Background/Purpose: Cost-related medication non-adherence (CRN) occurs when patients are unable to follow their prescribed medication regimen due to financial constraints, such as high costs or…
  • Abstract Number: 0512 • ACR Convergence 2023

    Factors Associated with Treatment Pathways in Early Axial Spondyloarthritis: A Multistate Analysis of the 10-year Follow-up of the DESIR Cohort

    Elodie Portier1, Sylvie chevret2, Adeline Ruyssen-Witrand3, Anouk Walter-Petrich2, Maxime Dougados4 and Anna Molto5, 1Hôpital Cochin, Paris, France, 2Saint Louis Hospital, Paris, France, 3Toulouse University Hospital, Toulouse, France, 4Rheumatology Department, Cochin Hospital; INSERM (U1153): Clinical Epidemiology and Biostatistics, University of Paris, Paris, France, 5HOPITAL COCHIN AP-HP, Service de Rhumatologie, Paris, France

    Background/Purpose: Current recommendations for the management of patients with axial spondyloarthritis (axSpA) emphasize the need of individualized strategy in the therapeutic decision. Thus, many factors…
  • Abstract Number: 0613 • ACR Convergence 2023

    Quantification of Skin Hardness of Patients with Systemic Sclerosis Using SOFTGRAM

    Hiraku Kokubu1, Yasuaki Ikuno1, Kazuyuki Uchiyama1, Miwa Kato1, Mayuka Yamamoto1, Haruki Asada1, Satona Rikitake1, Yoshimichi Kobayashi1, Takahiro Koike1, Syuji Sugiura1, Takuma Hayami1, Kensuke Yoneta1, Toshifumi Takahashi1, Bunpei Yamamoto1, Takeshi Kato1, Yoshito Kunisaki2, Makoto Nakatani2, Kohei Okamoto2 and Noriki Fujimoto1, 1Shiga University of Medical Science, Otsu, Japan, 2ISHIDA MEDICAL CO.,LTD., Kyoto, Japan

    Background/Purpose: No quantitative and objective methods for measuring skin hardness have been established. Japanese technology leads the world in the tactile sensor field, and SOFTGRAM…
  • 1
  • 2
  • 3
  • 4
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology